基因疗法开始从罕见病大本营向常见病高峰攀登

IF 12.6 1区医学 Q1 ALLERGY

Allergy Pub Date : 2024-06-25 DOI:10.1038/d41573-024-00109-0

Asher Mullard

引用次数: 0

摘要

AskBio 前首席运营官兼联合创始人裘德-萨穆斯基（Jude Samulski）探讨了基因疗法治疗复杂和常见疾病（包括帕金森病和充血性心力衰竭）的前景。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Gene therapies start the climb from rare disease base camps to common disease peaks

查看原文本刊更多论文

Gene therapies start the climb from rare disease base camps to common disease peaks

Jude Samulski, former CSO and co-founder of AskBio, discusses the future of gene therapy for complex and common diseases, including Parkinson disease and congestive heart failure. Jude Samulski, former CSO and co-founder of AskBio, discusses the future of gene therapy for complex and common diseases, including Parkinson disease and congestive heart failure.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Allergy 医学-过敏

CiteScore

26.10

自引率

9.70%

发文量

393

审稿时长

2 months

期刊介绍： Allergy is an international and multidisciplinary journal that aims to advance, impact, and communicate all aspects of the discipline of Allergy/Immunology. It publishes original articles, reviews, position papers, guidelines, editorials, news and commentaries, letters to the editors, and correspondences. The journal accepts articles based on their scientific merit and quality. Allergy seeks to maintain contact between basic and clinical Allergy/Immunology and encourages contributions from contributors and readers from all countries. In addition to its publication, Allergy also provides abstracting and indexing information. Some of the databases that include Allergy abstracts are Abstracts on Hygiene & Communicable Disease, Academic Search Alumni Edition, AgBiotech News & Information, AGRICOLA Database, Biological Abstracts, PubMed Dietary Supplement Subset, and Global Health, among others.